All News

Patients with addiction or mental health conditions may benefit from treatment with marijuana.

The new method makes breast imaging less risky, and can lessen false-positive readings.

A diagnostic diabetes breathalyzer may one day become a reality.

Around 14 million people have HIV worldwide – yet an estimated 40% don’t know they’re infected.

FDA approvea Relypsa, Inc.’s supplemental New Drug Application with label updates of Veltassa.

Phase 3 trials showed that empaglifloxin can reduce blood pressure in type 2 diabetes patients.

A hormone produced in the venom of the platypus and echidnas holds future potential to provide clues about treating diabetes, according to a study published in the Nature journal Scientific Reports.

MDMA, better known as ecstasy or “Molly” and 3,4-methylenedioxymethamphetamine, is predominantly dismissed as an illicit street drug abused by raucous club-goers.

A recently-published study explores the outcomes associated with the combination of DOACs and dual anti platelet therapy.

CDC officials now recommend routine use of the meningococcal conjugate vaccine for patients with HIV.

Many students apply for pharmacy residencies without understanding their benefits and disadvantages.

The For Your Sweetheart campaign aims to improve education about the link between heart disease and diabetes.

Study captures major changes in infectious diseases between 1980 through 2014.

New treatments show promise harnessing the immune system to attack late-stage skin cancer.

Unsealed court testimony emphasizes the problems with the merger among healthcare giants.

A newly developed hand-held breath analyzer tests for elevated levels of acetone, which is strongly associated with undiagnosed diabetes.

Trametinib targets a type of immune cell that inhibits T cell response in cancer.

Memantine increases the risk of developing pneumonia by 1.6 times.

Top news of the day from across the health care landscape.

The new tool will allow physicians to share data easier and supports quality patient care.

Recall issued for 30 lots of sterile products manufactured by Cantrell Drug Company.

A first-of-its-kind study successfully transferred an ovary from one individual to another.

The cost of providing essential medications may not be too costly in low- and middle-income countries.

Top news of the day from across the healthcare landscape.

Egalet has submitted a supplemental new drug application (sNDA) to the FDA for Oxaydo, (oxycodone HCl, USP) in favor of an abuse-deterrent label claim for the intravenous route of abuse.

Rheumatic and myocardial inflammation can be treated with disease modifying anti-rheumatic drugs.

Oral corticosteroids can cause a greater risk of side effects and higher total healthcare costs in chronic idiopathic urticaria.

The FDA has approved Relypsa, Inc.’s supplemental New Drug Application (sNDA) with label updates of Veltassa (patiromer) for oral suspension. Veltassa was approved by the FDA for the treatment of hyperkalemia on October 21, 2015.

Flu vaccinations during pregnancy do not seem to increase risk of autism spectrum disorders in children, according to a report published in JAMA Pediatrics.